Modern medicine is facing the convergence of 2 major problems: the rise of antibiotic resistance and the fall of efforts to find badly needed replacements, write Allan Coukell and Helen W. Boucher. In 2018 alone, 3 Big Pharma firms halted antibiotics R&D; others have…

Understanding US drug pricing can feel like a fool’s errand—Axios took a stab at it. While the US spends more on hospital care and doctor visits than prescription drugs, one drug's price can tip the spending scales—like hepatitis C treatments that sent spending spiraling in…